Literature DB >> 18043434

Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2.

Laurel M Fisher1, Joni K Doherty, Michael H Lev, William H Slattery.   

Abstract

OBJECTIVE: To describe the prevalence and location of cranial nerve schwannomas, other than bilateral vestibular schwannoma, in patients with neurofibromatosis 2 (NF2). The NF2 Natural History Consortium prospectively gathered cranial magnetic resonance imaging for 83 patients across 3 annual evaluations. The time between the first and last evaluation was approximately 3 years.
RESULTS: Forty-two patients (51%) had nonvestibular cranial nerve schwannomas (NVSs). Of these, 25 (60%) also had cranial meningiomas. Twenty-one of those without NVS (25% of 83) had at least 1 meningioma. The average size of the NVS was 0.4 cubic centimeters. Overall, there was no significant change in NVS size from Year 1 to Year 3 or from Year 1 to Year 2. The most common locations of the NVS were occulomotor and trigeminal. A family history of NF2 did not predict NVS location or growth.
CONCLUSION: Nonvestibular cranial nerve schwannoma usually affect cranial nerves III and V, as was the case in our NF2 sample. Fortunately, neuropathies associated with these tumors are rare. In contrast, lower cranial nerve schwannomas, although also rare, are associated with swallowing difficulty, aspiration, and other sequelae.

Entities:  

Mesh:

Year:  2007        PMID: 18043434     DOI: 10.1097/MAO.0b013e31815a8411

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  12 in total

Review 1.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

2.  Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.

Authors:  Michael S Dirks; John A Butman; H Jeffrey Kim; Tianxia Wu; Keaton Morgan; Anne P Tran; Russell R Lonser; Ashok R Asthagiri
Journal:  J Neurosurg       Date:  2012-04-13       Impact factor: 5.115

3.  Multimodality Management of Trigeminal Schwannomas.

Authors:  Ajay Niranjan; Samuel Barnett; Vijay Anand; Siviero Agazzi
Journal:  J Neurol Surg B Skull Base       Date:  2016-04-22

Review 4.  Familial syndromes associated with intracranial tumours: a review.

Authors:  Adrianna M Ranger; Yatri K Patel; Navjot Chaudhary; Ram V Anantha
Journal:  Childs Nerv Syst       Date:  2013-11-06       Impact factor: 1.475

Review 5.  Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.

Authors:  Scott R Plotkin; Chris Halpin; Jaishri O Blakeley; William H Slattery; D Bradley Welling; Susan M Chang; Jay S Loeffler; Gordon J Harris; A Gregory Sorensen; Michael J McKenna; Fred G Barker
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

6.  Prevalence and natural history of schwannomas in neurofibromatosis type 2 (NF2): the influence of pathogenic variants.

Authors:  Daniel Moualed; Jonathan Wong; Owen Thomas; Calvin Heal; Rukhtam Saqib; Cameron Choi; Simon Lloyd; Scott Rutherford; Emma Stapleton; Charlotte Hammerbeck-Ward; Omar Pathmanaban; Roger Laitt; Miriam Smith; Andrew Wallace; Mark Kellett; Gareth Evans; Andrew King; Simon Freeman
Journal:  Eur J Hum Genet       Date:  2022-01-24       Impact factor: 4.246

7.  Multiple primary cranio-spinal tumours in a 13-year-old female with neurofibromatosis type 2 management strategy.

Authors:  Teresa Stachowicz-Stencel; Anna Synakiewicz; Ewa Bien; Elzbieta Adamkiewicz-Drozynska; Miroslawa Wybieralska-Dubaniewicz; Anna Balcerska
Journal:  Childs Nerv Syst       Date:  2010-07-27       Impact factor: 1.475

Review 8.  The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.

Authors:  Hildegard Kehrer-Sawatzki; Said Farschtschi; Victor-Felix Mautner; David N Cooper
Journal:  Hum Genet       Date:  2016-12-05       Impact factor: 4.132

9.  Tumors displaying hybrid schwannoma and neurofibroma features in patients with neurofibromatosis type 2.

Authors:  Blake K Montgomery; Meghna Alimchandani; Gautam U Mehta; Ramita Dewan; Cody L Nesvick; Markku Miettinen; John D Heiss; Ashok R Asthagiri; Martha Quezado; Anand V Germanwala
Journal:  Clin Neuropathol       Date:  2016 Mar-Apr       Impact factor: 1.368

Review 10.  Genetic syndromes predisposing to pediatric brain tumors.

Authors:  Sameer Farouk Sait; Michael F Walsh; Matthias A Karajannis
Journal:  Neurooncol Pract       Date:  2021-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.